PIMAVANSERIN FOR TREATING IMPULSE CONTROL DISORDER
- 专利权人:
- ACADIA Pharmaceuticals Inc.
- 发明人:
- Ethan S. Burstein
- 申请号：
- US16607234
- 公开号：
- US20200061045A1
- 申请日:
- 2018.04.27
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- A method for treating a impulse control disorder in a patient comprising administering to the patient an effective amount of pimavanserin or a pharmaceutical acceptable salt thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROMUSCULAR DISORDERS AND NEURODEGENERATIVE DISORDERS
- Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
- TREATMENT OF COGNITIVE DISORDERS WITH (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
- PANOTHENATE DERIVATIVES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
- USE OF TRIFLUORMETIL-SUBSTITUTED BENZAMIDS IN THE TREATMENT OF NEUROLOGICAL DISORDERS
